Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
On today’s episode we discuss the latest hot topic in the fitness industry - weight loss drug, Retatrutide.
What are the benefits? Are there potential side effects? What does this mean for bikini competitors in prep, dieting hard for a show?
Follow us on IG
@preplifepodcast
@glamgirlbikini
@amyehinger
@leemarie183
Watch on YouTube: Glam Girl Bikini
Join the team: https://www.glamgirlbi...
1st Phorm Supplements we use:
https://1stphorm.com/?...
Key references
• Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity. N Engl J Med / related publications (phase-2 reports).
• Sanyal AJ, et al. Retatrutide and liver fat/liver outcomes. Nature Medicine 2024.
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP). N Engl J Med 2021.
• Jastreboff AM, et al. Tirzepatide once weekly for obesity (SURMOUNT) and related reports. PubMed/NEJM/SURMOUNT analyses.
• Conceição-Furber E, et al. Is glucagon receptor activation the thermogenic solution? Frontiers in Endocrinology, review of GCGR and energy expenditure mechanisms.
• Frampton J, et al. The acute effect of glucagon on components of energy expenditure. Int J Obes / Nature Metabolism meta-